DELRAY BEACH, Fla., (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America's homeland defense, today announced it has entered into an agreement with Simplex Healthcare, Inc. ("Simplex"), the parent company of the third largest mail order supplier of diabetic testing supplies, Diabetes Care Club, LLC ("DCC"), to provide PositiveID's iglucose(R) System for diabetes management to people with diabetes.
Simplex will purchase iglucose units and will begin trialing the iglucose mobile health diabetes management solution among its members.
PositiveID's FDA-cleared iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition.
By wirelessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared with family members and healthcare professionals. This makes it possible to improve care in a cost-effective manner. iglucose simplifies diabetes management by eliminating the burden of keeping logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition. iglucose is compatible with leading FDA-cleared glucometers and does not require the use of a cell phone or a wireless plan.
William J. Caragol, Chairman and CEO of PositiveID, said, "We are very pleased to be working with Simplex, a leader in the diabetic testing supply market. As a leader in this space, Simplex has a strong knowledge of what people with diabetes need to improve their self-management for better outcomes, which, we believe, is an important testimonial on the value proposition of iglucose."
Simplex Healthcare, Inc. was founded in April 2007 to provide home delivery of medical supplies for patients with diabetes. Since then, Diabetes Care Club(R) (DCC), a Simplex wholly owned subsidiary, has grown to become the third largest mail order supplier of diabetic testing supplies for seniors.
The iglucose System collects and transmits stored data from a variety of FDA-cleared blood glucose meters such as Johnson & Johnson LifeScan(R), Abbott FreeStyle(R), Bayer Contour(R), and Nipro
Diagnostic(TM) True(TM) monitoring systems to a secure database via wireless cellular technology. The Company is continually adding to this list of supported glucose meters. iglucose was recently awarded the Connected World Gold Value Chain Award for Home Health and was selected as a finalist in the Healthcare and Wellness Category of CTIA's annual Emerging Technology (E-Tech) Awards competition. For more information on iglucose, visit www.iglucose.com.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of advanced technologies for diabetes management and rapid medical testing, as well as airborne bio-threat detection systems for America's homeland defense. Its wholly-owned subsidiary, Microfluidic Systems, or MFS, is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.
For more information on PositiveID, please visit http://www.PositiveIDCorp.com.